EP1315510A4 - Procedes et compositions permettant la reparation et/ou la regeneration de myocarde endommage - Google Patents

Procedes et compositions permettant la reparation et/ou la regeneration de myocarde endommage

Info

Publication number
EP1315510A4
EP1315510A4 EP01961855A EP01961855A EP1315510A4 EP 1315510 A4 EP1315510 A4 EP 1315510A4 EP 01961855 A EP01961855 A EP 01961855A EP 01961855 A EP01961855 A EP 01961855A EP 1315510 A4 EP1315510 A4 EP 1315510A4
Authority
EP
European Patent Office
Prior art keywords
regeneration
repair
compositions
methods
damaged myocardium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01961855A
Other languages
German (de)
English (en)
Other versions
EP1315510A2 (fr
Inventor
Piero Anversa
Donald Orlic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New York Medical College
US Government
Original Assignee
New York Medical College
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York Medical College, US Department of Health and Human Services filed Critical New York Medical College
Publication of EP1315510A2 publication Critical patent/EP1315510A2/fr
Publication of EP1315510A4 publication Critical patent/EP1315510A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/12—Hepatocyte growth factor [HGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Microbiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Dental Preparations (AREA)
EP01961855A 2000-07-31 2001-07-31 Procedes et compositions permettant la reparation et/ou la regeneration de myocarde endommage Withdrawn EP1315510A4 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US22190200P 2000-07-31 2000-07-31
US221902P 2000-07-31
US25856400P 2000-12-29 2000-12-29
US258564P 2000-12-29
US25880501P 2001-01-02 2001-01-02
US258805P 2001-01-02
PCT/US2001/024223 WO2002013760A2 (fr) 2000-07-31 2001-07-31 Procedes et compositions permettant la reparation et/ou la regeneration de myocarde endommage

Publications (2)

Publication Number Publication Date
EP1315510A2 EP1315510A2 (fr) 2003-06-04
EP1315510A4 true EP1315510A4 (fr) 2005-08-03

Family

ID=27397004

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01961855A Withdrawn EP1315510A4 (fr) 2000-07-31 2001-07-31 Procedes et compositions permettant la reparation et/ou la regeneration de myocarde endommage

Country Status (4)

Country Link
EP (1) EP1315510A4 (fr)
AU (1) AU2001283088A1 (fr)
CA (1) CA2423592A1 (fr)
WO (1) WO2002013760A2 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7732199B2 (en) 2001-07-12 2010-06-08 Geron Corporation Process for making transplantable cardiomyocytes from human embryonic stem cells
US7425448B2 (en) 2001-07-12 2008-09-16 Geron Corporation Cardiomyocyte precursors from human embryonic stem cells
US7527968B2 (en) 2002-07-29 2009-05-05 Robarts Research Institute Regeneration initiating cells
ITRM20030376A1 (it) 2003-07-31 2005-02-01 Univ Roma Procedimento per l'isolamento e l'espansione di cellule staminali cardiache da biopsia.
US7452718B2 (en) 2004-03-26 2008-11-18 Geron Corporation Direct differentiation method for making cardiomyocytes from human embryonic stem cells
US11660317B2 (en) 2004-11-08 2023-05-30 The Johns Hopkins University Compositions comprising cardiosphere-derived cells for use in cell therapy
CA2611809C (fr) 2005-06-22 2018-06-19 Geron Corporation Differenciation de cellules souches pluripotentes en cellules a lignage cardiomyocyte
DK1951864T3 (da) 2005-11-07 2014-07-28 Amorcyte Inc Sammensætninger og fremgangsmåder til reparation af vaskulær skade
US8637005B2 (en) 2005-11-07 2014-01-28 Amorcyte, Inc. Compositions and methods of vascular injury repair
US20110076255A1 (en) 2005-11-07 2011-03-31 Pecora Andrew L Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
WO2008011094A2 (fr) * 2006-07-18 2008-01-24 Robert Sackstein Induction par la cytokine de ligands de sélectine sur des cellules
CA2743698A1 (fr) 2007-11-30 2009-06-11 New York Medical College Compositions comprenant des cellules progenitrices vasculaires et myocytaires et procedes permettant de les utiliser
US8512696B2 (en) 2007-11-30 2013-08-20 Autologous, Llc Methods of isolating non-senescent cardiac stem cells and uses thereof
WO2009073594A1 (fr) 2007-11-30 2009-06-11 New York Medical College Procédés permettant de réduire le rejet de greffon et l'artériosclérose accélérée du greffon cardiaque par implantation de cellules souches autologues
AU2008333972A1 (en) * 2007-11-30 2009-06-11 New York Medical College Compositions comprising HDAC inhibitors and methods of their use in restoring stem cell function and preventing heart failure
CN101939418A (zh) 2008-01-30 2011-01-05 杰龙公司 用于培养干细胞衍生的心肌细胞的合成表面
BRPI0920976A2 (pt) 2008-12-03 2015-08-18 Amorcyte Inc Composições que melhoram a perfusão da area de infarto e metodos de restauração da lesão vascular.
US9845457B2 (en) 2010-04-30 2017-12-19 Cedars-Sinai Medical Center Maintenance of genomic stability in cultured stem cells
US9249392B2 (en) 2010-04-30 2016-02-02 Cedars-Sinai Medical Center Methods and compositions for maintaining genomic stability in cultured stem cells
US9884076B2 (en) 2012-06-05 2018-02-06 Capricor, Inc. Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy
WO2014028493A2 (fr) 2012-08-13 2014-02-20 Cedars-Sinai Medical Center Exosomes et acides micro-ribonucléiques pour la régénération de tissus
AU2015327812B2 (en) 2014-10-03 2021-04-15 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy
EP3402543B1 (fr) 2016-01-11 2021-09-08 Cedars-Sinai Medical Center Cellules dérivées de cardiosphères et exosomes sécrétés par ces cellules dans le traitement d'une insuffisance cardiaque à fraction d'éjection préservée
WO2017210652A1 (fr) 2016-06-03 2017-12-07 Cedars-Sinai Medical Center Exosomes dérivés de cdc pour le traitement des tachyarythmies ventriculaires
US11541078B2 (en) 2016-09-20 2023-01-03 Cedars-Sinai Medical Center Cardiosphere-derived cells and their extracellular vesicles to retard or reverse aging and age-related disorders
JP7336769B2 (ja) 2017-04-19 2023-09-01 シーダーズ―シナイ メディカル センター 骨格筋ジストロフィーを治療する方法及び組成物
EP3727351A4 (fr) 2017-12-20 2021-10-06 Cedars-Sinai Medical Center Vésicules extracellulaires modifiées pour une administration tissulaire améliorée

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998018486A1 (fr) * 1996-10-25 1998-05-07 Icogen Corporation Utilisation de la leptine pour stimuler l'hematopoiese
WO2000006701A1 (fr) * 1998-07-31 2000-02-10 Genzyme Corporation Amelioration du fonctionnement cardiaque par transplantation de cellules souches mesenchymateuses

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998018486A1 (fr) * 1996-10-25 1998-05-07 Icogen Corporation Utilisation de la leptine pour stimuler l'hematopoiese
WO2000006701A1 (fr) * 1998-07-31 2000-02-10 Genzyme Corporation Amelioration du fonctionnement cardiaque par transplantation de cellules souches mesenchymateuses

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
TOMITA S ET AL: "AUTOLOGOUS TRANSPLANTATION OF BONE MARROW CELLS IMPROVES DAMAGED HEART FUNCTION", CIRCULATION, AMERICAN HEART ASSOCIATION, DALLAS, TX, US, vol. 110, no. SUPPL 19, 9 November 1999 (1999-11-09), pages II - 247, XP000869909, ISSN: 0009-7322 *
TOMITA S ET AL: "AUTOTRANSPLANTED MESENCHYMAL STEM CELLS IMPROVE FUNCTION AFTER A MYOCARDIAL INFARCTION", CIRCULATION, AMERICAN HEART ASSOCIATION, DALLAS, TX, US, vol. 98, no. 17, SUPPL, 27 October 1998 (1998-10-27), pages I - 200, XP009032355, ISSN: 0009-7322 *

Also Published As

Publication number Publication date
WO2002013760A9 (fr) 2003-09-04
CA2423592A1 (fr) 2002-02-21
AU2001283088A1 (en) 2002-02-25
WO2002013760A2 (fr) 2002-02-21
WO2002013760A3 (fr) 2002-04-18
EP1315510A2 (fr) 2003-06-04

Similar Documents

Publication Publication Date Title
AU2001284695A1 (en) Methods and compositions for the repair and/or regeneration of damaged myocardium
EP1315510A4 (fr) Procedes et compositions permettant la reparation et/ou la regeneration de myocarde endommage
IL215423A0 (en) Methods and compositions for the repair and/or regeneration of damaged myocardium
AU6623301A (en) Colchinol derivatives as vascular damaging agents
NZ514350A (en) Compositions and methods for effecting the levels of cholesterol
EP1452191A3 (fr) Echafaudage de tissu poreux pour la réparation ou la régénération de tissu
IS5053A (is) 6-Fenýlpýridýl-2-amín afleiður nytsamlegar sem nituroxíð sýntasa tálmar
AU2001280604A1 (en) Compositions comprising icariside i and anhydroicaritin and methods for making the same
AU5294100A (en) Method and compositions for treating the inflammatory response
EP1177277A4 (fr) Compositions et procedes convenant a la modification de la transcription de genes
GB9929566D0 (en) Corrosion inhibiting compositions and methods
GB0407513D0 (en) Method of railroad repair
IL148803A0 (en) Novel composition and method for stabilizing the same
HUP0600227A2 (en) Method of repairing or restoring damaged or defective hair
IL154422A0 (en) Paroxetine compositions and processes for making the same
AU2001234782A1 (en) Compositions and methods for promoting healthy joints
EP1404775A4 (fr) Pigments anticorrosion et leur procede de fabrication
EP1139981A4 (fr) Compositions et procedes d'utilisation associes
AU2756301A (en) Compositions comprising genome segments and methods of using the same
EP1277459A4 (fr) Compositions de frisage et methode de frisage utilisant ces compositions
EP1163340A4 (fr) Compositions et methodes de modification de l'expression genique
AU2003268340A8 (en) Methods and compositions for the inhibition of dna repair protein xrcc-3
AU2002217915A1 (en) Compositions and methods for diagnosing or treating psoriasis
EP1549761A4 (fr) Procedes et compositions permettant de modifier des acides nucleiques
AU5931300A (en) Ringene compositions and methods for use thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030226

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS

Owner name: NEW YORK MEDICAL COLLEGE

A4 Supplementary search report drawn up and despatched

Effective date: 20050616

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61P 9/10 B

Ipc: 7A 61K 35/28 A

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060301